0001437749-22-012711.txt : 20220516 0001437749-22-012711.hdr.sgml : 20220516 20220516182120 ACCESSION NUMBER: 0001437749-22-012711 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220513 FILED AS OF DATE: 20220516 DATE AS OF CHANGE: 20220516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Remmel H. Lawrence CENTRAL INDEX KEY: 0001551817 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 22931505 MAIL ADDRESS: STREET 1: C/O ATOSSA GENETICS, INC. STREET 2: 4105 MADISON STREET, SUITE 320 CITY: SEATTLE STATE: WA ZIP: 98112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4 1 rdgdoc.xml FORM 4 X0306 4 2022-05-13 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001551817 Remmel H. Lawrence C/O ATOSSA THERAPEUTICS, INC., 107 SPRING STREET SEATTLE WA 98104 1 Stock Option (right to buy) 0.93 2022-05-13 4 A 0 50000 0 A 2032-05-13 Common Stock 50000 50000 D The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:30 a.m. (ET) on May 13, 2022, with an exercise price of $0.93, representing the most recently reported closing stock price on May 12, 2022. /s/ H. Lawrence Remmel 2022-05-16